Key Points
-
Small colony variants (SCVs) of bacteria were first described almost 100 years ago. The first description of the SCV phenotype was for Salmonella enterica serovar Typhi (S. typhi), but SCVs have now been reported for a wide range of bacterial genera and species, including Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa. Most data have been collected for Staphylococcus aureus SCVs, so S. aureus SCVs are the focus of this Review article.
-
As their name implies, the most conspicuous feature of SCVs is their colony size — SCVs form colonies that are almost one-tenth the size of colonies associated with wild-type bacteria. In addition, SCVs have fastidious growth requirements and therefore present a challenge to clinical microbiologists.
-
In bacteria, slow growth can be caused by a variety of metabolic alterations. However, two defects are consistently associated with S. aureus SCVs isolated from clinical specimens: a deficiency in electron transport, and a deficiency in thymidine biosynthesis. Electron-transport-defective SCVs have a defect in the biosynthesis of menadione or haemin. Several mutations can produce the electron-transport-defective SCV phenotype, including mutations in menD and hemB, but the genetic basis of the electron-transport deficiency in vivo remains undefined and is a key area for future research. Curiously, the phenotype of thymidine-auxotrophic SCVs is nearly identical to that of SCVs with an electron-transport deficiency, and the basis for this is not understood. Again, the genetic basis of the thymidine deficiency in vivo is undefined and is a key area for future research. In this article, however, we propose that thymidine auxotrophs are double mutants, with a mutation in the gene that encodes NupC (a membrane-spanning protein involved in thymidine uptake) in addition to a mutation in the gene that encodes thymidylate synthase (ThyA).
-
The specific disease states associated with SCV infection that are discussed here include cystic fibrosis and osteomyelitis. For the past decade, researchers have been investigating the connection between the SCV phenotype and persistent, recurrent infections; however, in this Review, we highlight that S. aureus SCVs can also cause aggressive infections in humans and animal models, and we suggest that SCVs are part of the normal life cycle of staphylococci.
-
The incidence of SCVs in clinical specimens varies between studies and can be as high as 30% and as low as <1%. We suggest, however, that the SCV phenotype is not rare but, instead, is extremely difficult to recover. The issues that are associated with isolating and identifying SCVs in the clinical microbiology laboratory are also discussed.
Abstract
Small colony variants constitute a slow-growing subpopulation of bacteria with distinctive phenotypic and pathogenic traits. Phenotypically, small colony variants have a slow growth rate, atypical colony morphology and unusual biochemical characteristics, making them a challenge for clinical microbiologists to identify. Clinically, small colony variants are better able to persist in mammalian cells and are less susceptible to antibiotics than their wild-type counterparts, and can cause latent or recurrent infections on emergence from the protective environment of the host cell. This Review covers the phenotypic, genetic and clinical picture associated with small colony variants, with an emphasis on staphylococci, for which the greatest amount of information is available.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Proctor, R. A., Bates, D. M. & McNamara, P. J. in Emerging Infections Vol. 5 (ed. Craig, W.) 95–110 (American Society for Microbiology Press, Washington DC, 2001).
Jacobsen, K. A. Mitteilungen über einen variablen Typhusstamm (Bacterium typhi mutabile), sowie über eine eigentümliche hemmende Wirkung des gewöhnlichen agar, verursacht durch autoklavierung. Zentralbl. Bakteriol. [Orig. A] 56, 208–216 (1910) (in German).
Jensen, J. Biosynthesis of hematin compounds in a hemin requiring strain of Micrococcus pyogenes var. aureus. I. The significance of coenzyme A for the terminal synthesis of catalase. J. Bacteriol. 73, 324–333 (1957).
Bulger, R. J. A methicillin-resistant strain of Staphylococcus aureus. Clinical and laboratory experience. Ann. Intern. Med. 67, 81–89 (1967).
Baddour, L. M., Barker, L. P., Christensen, G. D., Parisi, J. T. & Simpson, W. A. Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes. J. Clin. Microbiol. 28, 676–679 (1990).
von Eiff, C. et al. Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin. Infect. Dis. 29, 932–934 (1999).
Bryan, L. E. & Kwan, S. Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrate reductase, and aerobic transport. Antimicrob. Agents Chemother. 19, 958–964 (1981).
Häussler, S. et al. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur. J. Clin. Microbiol. Infect. Dis. 22, 249–253 (2003).
Duff, D. C. B. Dissociation in Bacillus salmonicida with special reference to the appearance of G form of cultures. J. Bacteriol. 34, 49–58 (1937).
Swingle, E. L. Studies on small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 31, 891–893 (1934).
Hadley, P., Delves, E. & Klimek, J. The filterable forms of bacteria. I. A filterable stage in the life history of the Shiga dysentery bacillus. J. Infect. Dis. 48, 1–16 (1931).
Hall, W. H. & Spink, W. W. In vitro sensitivity of Brucella to streptomycin — development of resistance during streptomycin treatment. Proc. Soc. Exp. Biol. Med. 64, 403–406 (1947).
Colwell, C. A. Small colony variants of Escherichia coli. J. Bacteriol. 52, 417–422 (1946).
Kopeloff, N. Dissociation and filtration of Lactobacillus acidophilus. J. Infect. Dis. 55, 368–389 (1934).
Muhammad, M., Miller, F. E., Schor, J. & Kocka, F. E. Small-colony forms of enteric bacteria after exposure to aminoglycosides. Am. J. Clin. Pathol. 72, 79–81 (1979).
Raven, C. Dissociation of the gonococcus. J. Infect. Dis. 55, 328–334 (1934).
Seifert, H., von Eiff, C. & Fätkenheuer, G. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg. Infect. Dis. 5, 450–453 (1999).
Kipp, F. et al. Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J. Neurol. Neurosurg. Psychiatry 74, 1000–1002 (2003).
Sherris, J. C. Two small colony variants of Staphylococcus aureus isolated in pure culture from closed infected lesions and their carbon dioxide requirements. J. Clin. Pathol. 5, 354–355 (1952).
Thomas, M. E. M. & Cowlard, J. H. Studies on a CO2-dependent Staphylococcus. J. Clin. Pathol. 8, 288–291 (1955).
Goudie, J. G. & Goudie, R. B. Recurrent infection by a stable-dwarf-colony variant of Staphylococcus aureus. J. Clin. Pathol. 8, 284–287 (1955).
Slifkin, M., Merkow, L. P., Kreuzberger, S. A., Engwall, C. & Pardo, M. Characterization of CO2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56, 584–592 (1971).
Acar, J. F., Goldstein, F. W. & Lagrange, P. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J. Clin. Microbiol. 8, 142–147 (1978).
Lacy, R. W. Dwarf-colony variants of Staphylococcus aureus resistant to aminoglycoside antibiotics and to a fatty acid. J. Med. Microbiol. 2, 187–197 (1969).
Hale, J. H. Studies on Staphylococcus mutation: a naturally occurring 'G' gonidial variant and its carbon dioxide requirements. Br. J. Exp. Pathol. 32, 307–313 (1951).
Wise, R. I. & Spink, W. W. The influence of antibiotics on the origin of small colonies (G variants) of Micrococcus pyogenes var. aureus. J. Clin. Invest. 33, 1611–1622 (1954).
Wise, R. I. Small colonies (G variants) of staphylococci: isolation from cultures and infections. Ann. NY Acad. Sci. 65, 169–174 (1956).
Spagna, V. A., Fass, R. J., Prior, R. B. & Slama, T. G. Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus. J. Infect. Dis. 138, 277–278 (1978).
Sompolinsky, D., Schwartz, D., Samra, Z., Steinmetz, J. & Siegman-Igra, Y. Septicemia with two distinct strains of Staphylococcus aureus and dwarf variants of both. Isr. J. Med. Sci. 21, 434–440 (1985).
Baddour, L. M. & Christensen, G. D. Prosthetic valve endocarditis due to small-colony staphylococcal variants. Rev. Infect. Dis. 9, 1168–1174 (1987).
Youmans, G. P. Production of small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 36, 94–96 (1937).
Nydahl, B. C. & Hall, W. L. The treatment of staphylococcal infection with nafcillin with a discussion of staphylococcal nephritis. Ann. Intern. Med. 63, 27–43 (1965).
von Eiff, C. et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25, 1250–1251 (1997).
Rolauffs, B., Bernhardt, T. M., von Eiff, C., Hart, M. L. & Bettin, D. Osteopetrosis, femoral fracture, and chronic osteomyelitis caused by Staphylococcus aureus small colony variants (SCV) treated by girdlestone resection — 6-year follow-up. Arch. Orthop. Trauma Surg. 122, 547–550 (2002). This paper describes a long-term prospective study identifying the role of SCVs.
Borderon, E. & Horodniceanu, T. Mutants déficients a colonies naines de Staphylococcus: ètude de trois souches isolées chez des malades porteurs d'osteosyntheses. Ann. Microbiol. (Paris) 127, 503–514 (1976) (in French).
Hoffstadt, R. E. & Youmans, G. P. Staphylococcus aureus: dissociation and its relation to infection and to immunity. J. Infect. Dis. 51, 216–242 (1932).
von Eiff, C., Lindner, N., Proctor, R. A., Winkelmann, W. & Peters, G. Development of gentamicin-resistant small colony variants of Staphylococcus aureus after implantation of gentamicin beads in osteomyelitis as a possible cause of recurrence. Z. Orthop. Ihre Grenzgeb. 136, 268–271 (1998) (in German).
Roggenkamp, A. et al. Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli. J. Clin. Microbiol. 36, 2530–2534 (1998).
Kahl, B. et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177, 1023–1029 (1998).
Sadowska, B. et al. Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants. FEMS Immunol. Med. Microbiol. 32, 191–197 (2002).
Kahl, B. C. et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J. Clin. Microbiol. 41, 4424–4427 (2003).
von Eiff, C. et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin. Infect. Dis. 32, 1643–1647 (2001).
Seifert, H., Wisplinghoff, H., Schnabel, P. & von Eiff, C. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg. Infect. Dis. 9, 1316–1318 (2003).
Lacy, R. W. & Mitchell, A. A. B. Gentamicin-resistant Staphylococcus aureus. Lancet 2, 1425–1426 (1969).
Sompolinsky, D., Cohen, M. & Ziv, G. Epidemiological studies on thiamine-less dwarf-colony variants of Staphylococcus aureus as etiologic agents of bovine mastitis. Infect. Immun. 9, 217–228 (1974).
Thomas, M. E. M. & Cowlard, J. H. Studies on a CO2-dependent Staphylococcus. J. Clin. Pathol. 8, 288–291 (1955).
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N. & Arbeit, R. D. Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20, 95–102 (1995). This was the first paper to describe a distinct SCV-associated clinical syndrome.
Proctor, R. A. in Gram-Positive Pathogens Ch. 35 (eds Fischetti, V. A., Novick, R. P., Ferretti, J. J., Portnoy, D. A. & Rood, J. I.) (American Society for Microbiology Press, Washington DC, in the press).
Proctor, R. A. in Infections Associated with Indwelling Medical Devices Ch. 3 (eds Waldvogel, F. & Bisno, A. L.) 41–54 (American Society for Microbiology Press, Washington DC, 2000).
Proctor, R. A., Balwit, J. M. & Vesga, O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 3, 302–312 (1994).
Saxild, H. H., Andersen, L. N. & Hammer, K. dra-nupC-pdp operon of Bacillus subtilis: nucleotide sequence, induction by deoxyribonucleosides, and transcriptional regulation by the deoR-encoded DeoR repressor protein. J. Bacteriol. 178, 424–434 (1996).
Smith, K. M. et al. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J. Biol. Chem. 280, 25436–25449 (2005).
Slifkin, M., Merkow, L. P., Kreuzberger, S. A., Engwall, C. & Pardo, M. Characterization of CO2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56, 584–592 (1971).
Ross, R. A. & Onderdonk, A. B. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infect. Immun. 68, 5205–5209 (2000).
von Eiff, C. et al. A site directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellularly. J. Bacteriol. 179, 4706–4712 (1997).
Bates, D. M. et al. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J. Infect. Dis. 187, 1654–1661 (2003). This was the first animal model showing that genetically defined SCVs can persist in host tissues.
Clements, M. O., Watson, S. P., Poole, R. K. & Foster, S. J. CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis. J. Bacteriol. 181, 501–507 (1999).
Cano, D. A., Pucciarelli, M. G., Martinez-Moya, M., Casadesus, J. & Garcia-del Portillo, F. Selection of small-colony variants of Salmonella enterica serovar Typhimurium in nonphagocytic eucaryotic cells. Infect. Immun. 71, 3690–3698 (2003).
Balwit, J. M., van Langevelde, P., Vann, J. M. & Proctor, R. A. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170, 1033–1037 (1994). This paper laid the biochemical basis for SCVs, identified interruption in electron transport as a link between many SCV phenotypes that had been previously reported, and showed that SCVs could persist in cultured mammalian cells.
Vann, J. M. & Proctor, R. A. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus α-hemolysin. Microb. Pathog. 4, 443–453 (1988). This paper showed that S. aureus can persist in mammalian cells and laid the groundwork for studies of SCVs.
Vaudaux, P. et al. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70, 5428–5437 (2002). This paper showed that SCVs have higher expression of surface adhesins than their isogenic parent and therefore have increased virulence despite their slow growth rate.
Baumert, N. et al. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 8, 253–260 (2002).
Miller, M. H., Edberg, S. C., Mandel, L. J., Behar, F. C. & Steigbigel, N. H. Gentamicin uptake in wild type and aminoglycoside-resistant small colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18, 722–729 (1980).
Kohler, C. et al. Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J. Bacteriol. 185, 6928–6937 (2003). This paper describes the first detailed study of the changes occurring in metabolic pathways in SCVs.
Koo, S.-P., Bayer, A. S., Sahl, H.-G., Proctor, R. A. & Yeaman, M. R. Staphylocidal action of thrombin-induced platelet microbicidal protein (tPMP) is not solely dependent on transmembrane potential. Infect. Immun. 64, 1070–1074 (1996). This paper shows one mechanism by which SCVs could be more resistant to antibiotics.
Proctor, R. A. Bacterial energetics and antimicrobial resistance. Drug Resist. Updat. 1, 227–235 (1998).
von Eiff, C., Friedrich, A. W., Becker, K. & Peters, G. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrob. Agents Chemother. 49, 4372–4374 (2005).
Morton, H. E. & Shoemaker, J. The identification of Neisseria gonorrhoeae by means of bacterial variation and the detection of small colony forms in clinical material. J. Bacteriol. 50, 585–590 (1945).
Sasarman, A., Sanderson, K. E., Surdeanu, M. & Sonea, S. Hemin-deficient mutants of Salmonella typhimurium. J. Bacteriol. 102, 531–536 (1970).
Bayer, A. S., Norman, D. C. & Kim, K. S. Characterization of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis. Antimicrob. Agents Chemother. 31, 70–75 (1987).
Chinn, B. D. Characteristics of small colony variants with special reference to Shigella paradysenteriae sonne. J. Infect. Dis. 59, 137–151 (1936).
Chinn, B. D. Characteristics of small colony variants of Shigella paradysenteriae sonne and Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 34, 237–238 (1936).
Li, K., Farmer, J. J. & Coppola, A. A novel type of resistant bacteria induced by gentamicin. Trans. NY Acad. Sci. 36, 396–415 (1974).
Gilligan, P. H., Gage, P. A., Welch, D. F., Muszynski, M. J. & Wait, K. R. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J. Clin. Microbiol. 25, 1258–1261 (1987).
Stryer, L. in Biochemistry 739–762 (Freeman and Company, New York, 1995).
Kahl, B. C. et al. A thymidine-dependent small colony variant (SCV) has a 3 bp deletion in the thymidylate synthase (thy) gene and is complemented by a functional thy. Abstract BO200. Annual Meeting of the German Society of Hygiene and Microbiology (Goettingen, Germany, 25–28 Sep 2005).
Kahl, B. C. et al. Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J. Clin. Microbiol. 41, 410–413 (2003).
Abell, E. L., Rosato, A. E., Archer, G. L. & Forbes, B. A. Clinical and microbiologic characterization of small colony variants (SCVs) of Staphylococcus aureus. Abstract D-052. American Society for Microbiology 105th General Meeting (Atlanta, Georgia, USA, 5–9 June 2005).
Kahl, B. C. et al. Thymidine-dependent Staphylococcus aureus small colony variants are associated with extensive changes in regulator and virulence gene expression profiles. Infect. Immun. 73, 4119–4126 (2005).
Spearman, P. et al. Sternoclavicular joint septic arthritis with small-colony variant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 26, 13–15 (1996).
Abele-Horn, M., Schupfner, B., Emmerling, P., Waldner, H. & Goring, H. Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection 28, 53–54 (2000).
Adler, H., Widmer, A. & Frei, R. Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur. J. Clin. Microbiol. Infect. Dis. 22, 746–748 (2003).
von Eiff, C., Lubritz, G., Heese, C., Peters, G. & Becker, K. Effect of trimethoprim-sulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 48, 191–194 (2004).
Salgado, D. R., Boza, F. A., Pinto, M. & Sampaio, J. Outbreak with small colony variants of methicillin-resistant Staphylococcus aureus in an ICU. Abstract K-1226. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, Illinois, USA, 16–19 Dec 2001).
Spanu, T. et al. Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 41, 48–52 (2005).
Häussler, S., Tummler, B., Weissbrodt, H., Rohde, M. & Steinmetz, I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29, 621–625 (1999).
Häussler, S., Rohde, M. & Steinmetz, I. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med. Microbiol. Immunol. (Berl.) 188, 91–97 (1999).
von Götz, F. et al. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J. Bacteriol. 186, 3837–3847 (2004).
Häussler, S. et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol. 52, 295–301 (2003).
Häussler, S., Tummler, B., Weissbrodt, H., Rohde, M. & Steinmetz, I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29, 621–625 (1999).
Fleiszig, S. M., Arora, S. K., Van, R. & Ramphal, R. FlhA, a component of the flagellum assembly apparatus of Pseudomonas aeruginosa, plays a role in internalization by corneal epithelial cells. Infect. Immun. 69, 4931–4937 (2001).
Badenoch, P. R. & Coster, D. J. Selection of gentamicin-resistant variants of Pseudomonas aeruginosa in the rat cornea. J. Ocul. Pharmacol. 5, 19–25 (1989).
Chambers, H. F. & Miller, M. M. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect. Dis. 155, 581–585 (1987).
Musher, D. M., Baughn, R. E., Templeton, G. B. & Minuth, J. N. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J. Infect. Dis. 136, 360–369 (1977).
Wilson, S. G. & Sanders, C. C. Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides. Antimicrob. Agents Chemother. 10, 519–525 (1976).
Chuard, C., Vaudaux, P. E., Proctor, R. A. & Lew, D. P. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J. Antimicrob. Chemother. 39, 603–608 (1997). This paper showed that SCVs are extremely resistant to antibiotics when present as a biofilm and in stationary phase.
Sinha, B. et al. Fibronectin-binding protein acts as Staphylococcus aureus invasion via fibronectin bridging to integrin α5β1 . Cell. Microbiol. 1, 101–117 (1999).
Hudson, M. C., Ramp, W. K., Nicholson, N. C., Williams, A. S. & Nousiainen, M. T. Internalization of Staphylococcus aureus by cultured osteoblasts. Microb. Pathog. 19, 409–419 (1995).
Hamill, R. J., Vann, J. M. & Proctor, R. A. Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect. Immun. 54, 833–836 (1986).
Bayles, K. W. et al. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect. Immun. 66, 336–342 (1998).
Kahl, B. C. et al. Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 68, 5385–5392 (2000).
Dziewanowska, K. et al. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect. Immun. 67, 4673–4678 (1999).
Peacock, S. J., Foster, T. J., Cameron, B. J. & Berendt, A. R. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 145, 3477–3486 (1999).
Vesga, O., Groeschel, M. C., Otten, M. F., Proctor, R. A. & Vann, J. M. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 173, 739–742 (1996). This paper showed that the host intracellular milieu (probably cationic peptides, as indicated in reference 65) can select for SCVs at an extremely high rate.
Bantel, H. et al. α-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic pathway independently of death receptor signaling. J. Cell Biol. 155, 637–648 (2001).
Haslinger, B., Strangfeld, K., Peters, G., Schulze-Osthoff, K. & Sinha, B. Staphylococcus aureus α-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-α and the mitochondrial death pathway. Cell. Microbiol. 5, 729–741 (2003).
Quie, P. G. Microcolonies (G-variants) of Staphylococcus aureus. Yale J. Biol. Med. 41, 394–403 (1969).
Pelletier, L. L. Jr, Richardson, M. & Feist, M. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J. Lab. Clin. Med. 94, 324–334 (1979).
Miller, M. H., Wexler, M. A. & Steigbigel, N. H. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin mutants. Antimicrob. Agents Chemother. 14, 336–343 (1978).
Brouillette, E., Martinez, A., Boyll, B. J., Allen, N. E. & Malouin, F. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol. Med. Microbiol. 41, 35–41 (2004).
Jonsson, I.-M. et al. Virulence of a hemB mutant Staphylococcus aureus small colony variant in a murine model of septic arthritis. Microb. Pathog. 34, 73–79 (2003).
Massey, R. C., Buckling, A. & Peacock, S. J. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11, 1810–1814 (2001). This report showed that SCVs form at a high rate.
Massey, R. C. & Peacock, S. J. Antibiotic-resistant sub-populations of the pathogenic bacterium Staphylococcus aureus confer population-wide resistance. Curr. Biol. 12, R686–R687 (2002).
Heinemann, M., Kummel, A., Ruinatscha, R. & Panke, S. In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network. Biotechnol. Bioeng. 92, 850–864 (2005).
Proctor, R. A. & Peters, G. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin. Infect. Dis. 27, 419–422 (1998).
von Eiff, C. & Becker, K. in MRSA: Current Perspectives (eds Fluit, A. C. & Schmitz, F.-J.) 253–273 (Caister Academic, Wymondham, 2003).
Kipp, F. et al. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small colony variants. J. Clin. Microbiol. 43, 1956–1959 (2005).
Becker, K. et al. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42, 4988–4995 (2004). References 117 and 118 identify optimal conditions for the recovery of SCVs.
Kipp, F., Becker, K., Peters, G. & von Eiff, C. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J. Clin. Microbiol. 42, 1277–1279 (2004).
Borderon, E. & Horodniceanu, T. Metabolically deficient dwarf-colony mutants of Escherichia coli: deficiency and resistance to antibiotics of strains isolated from urine culture. J. Clin. Microbiol. 8, 629–634 (1978).
Borderon, E., Horodniceanu, T., Buissiere, J. & Barthez, J. P. Mutants déficients à colonies naines de Escherichia coli: ètude d'une souche thiamine-déficiente isolée d'une uroculture. Ann. Microbiol. (Paris) 128A, 413–417 (1977) (in French).
Morris, J. F., Barnes, C. G. & Sellers, T. F. An outbreak of typhoid fever due to the small colony variety of Eberthella typhosa. Am. J. Public Health 33, 246–248 (1943).
Acknowledgements
A list of additional references related to SCVs is available online (see Supplementary information S2 (box)). This work was supported by grants from the National Institutes of Health (United States) to R.A.P. and P.M., by a grant from the Bundesministerium für Bildung und Forschung (Germany) (Pathogenomic Network: Alliance Gram-positive cocci, Project staphylococci) to C.v.E., K.B. and G.P., and by grants from the Deutsche Forschungsgemeinschaft (Germany) to B.C.K. and C.v.E.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Related links
Related links
DATABASES
Entrez Genome Project
FURTHER INFORMATION
Rights and permissions
About this article
Cite this article
Proctor, R., von Eiff, C., Kahl, B. et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4, 295–305 (2006). https://doi.org/10.1038/nrmicro1384
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1384
This article is cited by
-
A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis
BMC Pulmonary Medicine (2023)
-
Staphylococcus aureus host interactions and adaptation
Nature Reviews Microbiology (2023)
-
Promising applications of D-amino acids in periprosthetic joint infection
Bone Research (2023)
-
Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages
Drug Delivery and Translational Research (2023)
-
Gallibacterium anatis infection in poultry: a comprehensive review
Tropical Animal Health and Production (2023)